These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29658149)

  • 1. Coagulation parameters following equine herpesvirus type 1 infection in horses.
    Wilson ME; Holz CL; Kopec AK; Dau JJ; Luyendyk JP; Soboll Hussey G
    Equine Vet J; 2019 Jan; 51(1):102-107. PubMed ID: 29658149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
    Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
    J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses.
    Goehring LS; van Maanen C; Berendsen M; Cullinane A; de Groot RJ; Rottier PJ; Wesselingh JJ; Sloet van Oldruitenborgh-Oosterbaan MM
    Vet J; 2010 Nov; 186(2):180-7. PubMed ID: 19726209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.
    Wilsterman S; Soboll-Hussey G; Lunn DP; Ashton LV; Callan RJ; Hussey SB; Rao S; Goehring LS
    Vet Microbiol; 2011 Apr; 149(1-2):40-7. PubMed ID: 21093993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine herpesvirus type 1 infection induces procoagulant activity in equine monocytes.
    Yeo WM; Osterrieder N; Stokol T
    Vet Res; 2013 Mar; 44(1):16. PubMed ID: 23497076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Host Factors Associated with the Development of Equine Herpesvirus Myeloencephalopathy by Transcriptomic Analysis of Peripheral Blood Mononuclear Cells from Horses.
    Zarski LM; Giessler KS; Jacob SI; Weber PSD; McCauley AG; Lee Y; Soboll Hussey G
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33668216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma D-dimer concentrations during experimental EHV-1 infection of horses.
    Goehring LS; Soboll Hussey G; Gomez Diez M; Benedict K; Maxwell LK; Morley PS; Sloet van Oldruitenborgh-Oosterbaan MM; Lunn DP
    J Vet Intern Med; 2013; 27(6):1535-42. PubMed ID: 24112533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
    Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
    Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between equine herpesvirus-1 viremia and abortion or equine herpesvirus myeloencephalopathy in domesticated horses: A systematic review.
    Soboll-Hussey G; Dorman DC; Burgess BA; Goehring L; Gross P; Neinast C; Osterrieder K; Pusterla N; Lunn DP
    J Vet Intern Med; 2024; 38(3):1872-1891. PubMed ID: 38069576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1.
    Allen GP; Breathnach CC
    Equine Vet J; 2006 May; 38(3):252-7. PubMed ID: 16706281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the immune response to the pathogenesis of equine herpesvirus-1 (EHV-1): Are there immune correlates that predict increased risk or protection from EHV-1 myeloencephalopathy?
    Hussey GS; Giessler KS
    Vet J; 2022 Apr; 282():105827. PubMed ID: 35405348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report.
    Walter J; Seeh C; Fey K; Bleul U; Osterrieder N
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2016 Oct; 44(5):313-317. PubMed ID: 27652372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viremia and nasal shedding for the diagnosis of equine herpesvirus-1 infection in domesticated horses.
    Pusterla N; Dorman DC; Burgess BA; Goehring L; Gross M; Osterrieder K; Soboll Hussey G; Lunn DP
    J Vet Intern Med; 2024; 38(3):1765-1791. PubMed ID: 38069548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased susceptibility of peripheral blood mononuclear cells to equine herpes virus type 1 infection upon mitogen stimulation: a role of the cell cycle and of cell-to-cell transmission of the virus.
    van der Meulen KM; Nauwynck HJ; Pensaert MB
    Vet Microbiol; 2002 Apr; 86(1-2):157-63. PubMed ID: 11888698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants.
    Vandekerckhove AP; Glorieux S; Gryspeerdt AC; Steukers L; Van Doorsselaere J; Osterrieder N; Van de Walle GR; Nauwynck HJ
    Vet Microbiol; 2011 Aug; 152(1-2):21-8. PubMed ID: 21536394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infection with equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions.
    Hussey GS; Goehring LS; Lunn DP; Hussey SB; Huang T; Osterrieder N; Powell C; Hand J; Holz C; Slater J
    Vet Res; 2013 Dec; 44(1):118. PubMed ID: 24308772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
    J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies.
    Eady NA; Holmes C; Schnabel C; Babasyan S; Wagner B
    J Virol; 2024 Jun; 98(6):e0025024. PubMed ID: 38742875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
    BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.